Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.
Novo Nordisk pops 8% after Hims & Hers pulls copycat Wegovy weight-loss pill
Related Posts
Fed Chair Powell indicates interest rate cuts ahead: ‘The time has come for policy to adjust’
Powell laid the groundwork for interest rate cuts ahead, though he declined to provide exact indications on timing or extent.
Optimizing Memory for Large-Scale NLP Models: A Look at MINI-SEQUENCE TRANSFORMER
The evolution of Transformer models has revolutionized natural language processing (NLP) by significantly advancing model performance and capabilities. However, this…
Anthropic’s Evaluation of Chain-of-Thought Faithfulness: Investigating Hidden Reasoning, Reward Hacks, and the Limitations of Verbal AI Transparency in Reasoning Models
A key advancement in AI capabilities is the development and use of chain-of-thought (CoT) reasoning, where models explain their steps…